Adaptive Proton Therapy for Pediatric Cancer

This trial tests a method to make proton therapy, a type of radiation treatment, more precise for children with certain cancers, such as solid tumors or Hodgkin's lymphoma. Researchers aim to determine how often treatment plans need adjustment when changes occur in a child's body during therapy. The primary goal is to ensure the treatment remains effective and safe by using regular low-dose imaging, such as CT scans and MRIs. Children with solid tumors receiving proton therapy at St. Jude Children's Research Hospital may qualify for this trial. As an unphased trial, this study offers a unique opportunity to advance treatment precision and safety for future pediatric cancer patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that proton beam therapy (PBT) is generally safe for children with cancer. Studies have found that it often leads to better outcomes and fewer long-term side effects compared to traditional radiation therapy. For example, PBT typically protects healthy tissues from excessive radiation, preserving normal brain functions and reducing the risk of developing other cancers later.

Regarding side effects, PBT is associated with a lower risk of heart problems compared to other radiation methods. This is particularly important for young patients who have many years ahead. Additionally, research indicates that survival rates for children receiving PBT are quite high. Specifically, one study showed a two-year overall survival rate of over 92%.

Researchers are excited about adaptive proton therapy for pediatric cancer because it offers a more precise and personalized approach compared to traditional radiation therapy. Unlike conventional methods, this treatment uses systematic on-therapy imaging, such as CT or MRI, to monitor and adjust the radiation dose in real-time, ensuring it accurately targets the tumor while sparing surrounding healthy tissue. This adaptive replanning capability could potentially reduce side effects and improve outcomes for young cancer patients, making it a promising advancement in pediatric oncology.

Studies have shown that proton therapy effectively treats cancers in children, significantly improving survival rates. For example, one study found survival rates at one and two years to be 97.2% and 92.0%, respectively. Proton therapy targets tumors more precisely while protecting healthy tissues, reducing long-term side effects. Research indicates better disease control and survival compared to traditional radiation methods. Additionally, proton therapy results in lower radiation exposure to healthy brain areas, crucial for protecting growing bodies. Overall, proton therapy offers a promising treatment for children with solid tumors or Hodgkin's lymphoma.